Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 143,271 | 161,759 | 119,156 | 48,087 | 27,371 |
| Cost of Goods | 96,519 | 107,937 | 82,108 | 20,646 | 8,760 |
| Gross Profit | 46,752 | 53,822 | 37,048 | 27,441 | 18,611 |
| Operating Expenses | 118,096 | 200,300 | 72,316 | 34,328 | 19,591 |
| Operating Income | -70,825 | -145,541 | -35,160 | -6,241 | -220 |
| Other Income | 4,567 | 714 | 6,134 | 4,960 | -2,978 |
| Pre-tax Income | -66,258 | -144,827 | -29,026 | -1,281 | -3,198 |
| Income Tax | 169 | -5,022 | -20,118 | -3,264 | -1,541 |
| Net Income Continuous | -66,427 | -139,805 | -8,908 | 1,983 | -1,657 |
| Net Income | $-66,427 | $-139,805 | $-8,908 | $1,983 | $-1,657 |
| EPS Basic Total Ops | -1.52 | -3.29 | -0.23 | 0.07 | -0.09 |
| EPS Basic Continuous Ops | -1.52 | -3.29 | -0.23 | 0.07 | -0.09 |
| EPS Diluted Total Ops | -1.52 | -3.29 | -0.23 | -0.06 | -0.09 |
| EPS Diluted Continuous Ops | -1.52 | -3.29 | -0.23 | 0.07 | -0.09 |
| EPS Diluted Before Non-Recurring Items | -1.04 | -0.69 | -0.55 | 0.01 | 0.08 |
| EBITDA(a) | $-58,517 | $-129,051 | $-22,174 | $-1,173 | $1,577 |